Rare diseases
Investigational molecules
Locations
Back to France84 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study evaluating the effect of levetiracetam on recovery in patients with intracerebral haemorrhage
FranceComparing tenecteplase and mechanical clot removal versus mechanical clot removal alone for adults with a large ischemic stroke
FranceComparing the timing of etoposide and dexamethasone treatment for patients with severe sporadic hemophagocytic lymphohistiocytosis in intensive care.
FranceStudy comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications
FranceStudy of pirtobrutinib combined with immuno-chemotherapy for previously untreated patients with symptomatic chronic lymphocytic leukemia
FranceStudy comparing low-dose versus standard-dose epinephrine for better brain recovery in patients with out-of-hospital cardiac arrest
FranceStudy comparing 3-week versus 6-week antibiotic treatment for patients with drained pyogenic liver abscess
FranceStudy of tocilizumab compared to placebo in patients with chronic chondrocalcinosis who did not respond to standard treatments
FranceStudy on Stopping Allopurinol or Febuxostat in Gout Patients in Remission
FranceStudy on Etoposide for Patients with Severe Hemophagocytic Lymphohistiocytosis in Intensive Care
FranceStudy on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant
FranceStudy on Switching from Dulaglutide to Tirzepatide for Adults with Type 2 Diabetes
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
